NSC |
Compound |
Enrichment |
Correlation |
NSC 654379 |
ANTINEOPLASTIC-654379 |
0.0480633950058471 |
0.06746953 |
NSC 663286 |
7-Chloro-6-N-(2-fluoroethylamino)-5,8-quinolinedione |
0.0480633950058471 |
0.25266464 |
NSC 678144 |
4H-1,3,6,2-Dioxazaphosphocinium, 4-hexadecyltetrahydro- 2,6,6-trimethyl-, bromide, 2-oxide |
0.0480633950058471 |
-0.18779675 |
NSC 696862 |
1H-1,4,7-Triazonine-1,4-diacetic acid, octahydro- |
0.0480633950058471 |
0.16118814 |
NSC 697748 |
9H-Quino[4,3,2-de][1,10]phenanthrolin-9-one, 2-(4-nitrophenyl)- |
0.0480633950058471 |
0.50385426 |
NSC 703315 |
Null |
0.0480633950058471 |
0.30224661 |
NSC 704556 |
Null |
0.0480633950058471 |
-0.049702995 |
NSC 724063 |
(3-nitro-benzylidene-hydrazinocarbonylmethylsulfanyl)-acetic acid (3-nitro-benzylidene)-hydrazide |
0.0480633950058471 |
-0.10586539 |
NSC 724780 |
(1S,4R,5R,12R,13S)-9-[(2-{[(1S,4R,5R,8R,12R,13S)-1,5-dimethy l)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadec -9-en-9-yl]methoxy}ethoxy)methyl]-1,5-dimethyl-10-(trifluoro methyl)-11,14,15 |
0.0480633950058471 |
0.20370081 |
NSC 732517 |
Dasatinib |
0.0480633950058471 |
-0.3178619 |